BDBM509232 N-tert-Butyl-3-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]benzamide::US11364246, Example 2::US20200361871A1, Example 2

SMILES CC(C)(C)NC(=O)c1cccc(NC(=O)Cc2cc(Cl)ccc2O)c1

InChI Key InChIKey=AVPMXKBMUHIWHC-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 509232   

TargetAnoctamin-1(Human)
Enterprise Therapeutics

US Patent
LigandPNGBDBM509232(US20200361871A1, Example 2 | N-tert-Butyl-3-[[2-(5...)
Affinity DataEC50:  270nMAssay Description:Compound activity was quantified by measuring the increase in current upon compound addition and expressing this as a percentage increase of baseline...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetAnoctamin-1(Human)
Enterprise Therapeutics

US Patent
LigandPNGBDBM509232(US20200361871A1, Example 2 | N-tert-Butyl-3-[[2-(5...)
Affinity DataEC50:  270nMAssay Description:Cell Culture and PreparationFisher rat thyroid (FRT) cells stably expressing human TMEM16A (TMEM16Aabc variant; Dr Luis Galietta, Insituto Giannina, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent